FY2026 · ended Mar 31, 2026 · Revenue $5.94B, +8.7% YoY · Filed May 29, 2026
STERIS plc (STE) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $5.9 billion and net income of $782.3 million. Free cash flow was $972.4 million. As of Jun 30, 2026 it held $482.3 million in cash and investments and $2.2 billion in total debt.
Revenue (TTM)
$6.04B
+8.4% vs year-ago TTM
Net income (TTM)
$805.00M
+24.5% vs year-ago TTM
Operating cash flow (TTM)
$1.29B
+1.9% vs year-ago TTM
Free cash flow (TTM)
$925.60M
+1.8% vs year-ago TTM
EPS (TTM)
$8.17
+25.1% vs year-ago TTM
Dividend per share (TTM)
$2.52
+10.5% vs year-ago TTM
Shares outstanding
97.60M
-0.8% vs prior year
Net cash
$-1.69B
as of Jun 30, 2026
Operating margin
18.9%
FY 2027
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- STE (NYSE)
- Fiscal year ends
- March 31
- Incorporated in
- Ireland
- Headquarters
- Dublin, Ireland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1757898
- Former names
- STERIS Ltd (until Mar 28, 2019)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
- Cadre Holdings, Inc. CDRE
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Mar 31, 2026 |
FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $5.9B | $5.5B | $5.1B | $4.5B | $4.2B |
| Operating income | $1.1B | $866.6M | $836.1M | $791.1M | $477.8M |
| Net income | $782.3M | $614.6M | $378.2M | $107.0M | $243.9M |
| Diluted EPS | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
| Operating cash flow | $1.3B | $1.1B | $973.3M | $756.9M | $684.8M |
| Free cash flow | $972.4M | $778.0M | $613.0M | $395.0M | $397.2M |
| Total assets | $10.7B | $10.1B | $11.1B | $10.8B | $11.4B |
| Total liabilities | $3.5B | $3.5B | $4.7B | $4.7B | $4.9B |
| Stockholders' equity | $7.2B | $6.6B | $6.3B | $6.1B | $6.5B |
| Cash and investments | $439.6M | $171.7M | $207.0M | $208.4M | $348.3M |
| Total debt | $2.2B | $2.3B | $3.5B | $3.3B | $3.4B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 13, 2026 | Oct 11, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 6, 2026 | Jul 31, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 6, 2026 | May 7, 2026 |
All 682 STERIS plc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.